TLX
Telix Pharmaceuticals
39 hedge funds and large institutions have $8.47M invested in Telix Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.09% more ownership
Funds ownership: 0.24% → 0.33% (+0.09%)
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.33M | |
| 2 | +$1.31M | |
| 3 | +$472K | |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
+$354K |
| 5 |
Mariner
Overland Park,
Kansas
|
+$352K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$317K | |
| 3 | -$111K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$34.7K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$18.4K |
